355 related articles for article (PubMed ID: 15381461)
21. Serum lactate dehydrogenase isoenzyme pattern in non-Hodgkin's lymphomas.
Ricerca BM; Storti S; Campisi S; Pagano L; Dalla Torre F; Marra R; Amato A; Mango G; Bizzi B
Int J Biol Markers; 1988; 3(4):237-42. PubMed ID: 3235851
[TBL] [Abstract][Full Text] [Related]
22. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
24. Serum lactate dehydrogenase is an important risk determinant in acute lymphocytic leukemia.
Fanin R; Zuffa E; Fasola G; Damiani D; Gallizia C; Michieli MG; Marcuzzi P; Russo D; Visani G; Resegotti L
Haematologica; 1989; 74(2):161-5. PubMed ID: 2501169
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
26. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease.
Schilling RF; McKnight B; Crowley JJ
J Lab Clin Med; 1982 Mar; 99(3):382-7. PubMed ID: 7057064
[TBL] [Abstract][Full Text] [Related]
28. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
29. High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
Terpos E; Katodritou E; Roussou M; Pouli A; Michalis E; Delimpasi S; Parcharidou A; Kartasis Z; Zomas A; Symeonidis A; Viniou NA; Anagnostopoulos N; Economopoulos T; Zervas K; Dimopoulos MA;
Eur J Haematol; 2010 Aug; 85(2):114-9. PubMed ID: 20477863
[TBL] [Abstract][Full Text] [Related]
30. [Tumor markers in malignant lymphoma].
Kato H; Ogura M
Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
32. Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis.
Lu R; Jiang M; Chen Z; Xu X; Hu H; Zhao X; Gao X; Guo L
PLoS One; 2013; 8(9):e74853. PubMed ID: 24086384
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of selected clinical prognostic factors in patients with non-granulomatous lymphomas].
Rolski J
Pol Merkur Lekarski; 1997 May; 2(11):324-6. PubMed ID: 9377682
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
[TBL] [Abstract][Full Text] [Related]
35. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A
Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909
[TBL] [Abstract][Full Text] [Related]
36. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
37. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of the determination of lactate dehydrogenase in acute leukemia and non-Hodgkin's lymphoma].
D'Angelo G; Giardini C; Calvano D
Minerva Med; 1989 Jun; 80(6):549-52. PubMed ID: 2747983
[TBL] [Abstract][Full Text] [Related]
40. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]